Free Newsletter
Vaccine may offer protection from black plague
An experimental vaccine created from genetically engineered plant cells appears to be effective against the Black Plague, which has bedeviled the world for centuries and is listed as a top bioterror threat. And because they've developed an oral version of the vaccine, researchers at the University of Central Florida say they can produce mass quantities at a low cost.
The scientists both injected rats and gave them an oral dose of the vaccine, and both proved effective. All of the rats infected with black plague died within three days while all the treated rats survived.
"It worked beautifully," says UCF Professor Henry Daniell about the oral version of the vaccine. "It's expensive to create an injectable vaccine. But with oral vaccines, it is quite cheap. You grow your plants and then you convert them into capsules."
- check out the press release
Related Article:
The challenges of infectious disease
Comments
Post new comment
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession




